On the contrary, PI3K/AKT inhibitor LY294002 can inhibit the invasion of gastric cancer cells and migration, which contributes to downexpression of p-AKT, p-GSK3β, and β-catenin in the cytoplasm and nucleus. This evidence concerns the gene GSK3B and gastric cancer.